CREG Antibodies

Santa Cruz Biotechnology features a diverse variety of CREG Antibodies for research focused on understanding CREG protein functions. CREG Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CREG, or Cellular Repressor of E1A Stimulated Genes, plays essential roles in cellular processes such as differentiation, proliferation, and apoptosis. CREG regulation maintains normal cellular function and influences various disease states, including cancer development. Research has shown that CREG expression levels correlate with specific cellular responses and disease outcomes. Understanding CREG's molecular mechanisms can reveal potential therapeutic targets. Investigating CREG's interaction with other proteins provides valuable insights into cellular signaling pathways. Advanced research techniques using monoclonal antibodies enable precise detection and analysis of CREG in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for CREG support researchers worldwide in advancing scientific understanding of cellular biology and disease mechanisms.